Optimally Navigating the ‘Next Normal’ for Oncology Clinical Trials, Upcoming Webinar Hosted by Xtalks

Share Article

In this free webinar, the featured speaker will discuss optimal strategies for navigating the ‘next normal’ in oncology clinical trials, and lessons learned to develop key operational process and adaptations. The presentation will cover where to run complex oncology trials and what decision factors are expected to most influence your choice of region in 2021/22.

There are a number of ‘next normal’ business considerations to be addressed as the industry moves forward into a post-COVID era.

Despite the many adaptations that have emerged over the course of 2020 and into 2021 to ensure oncology clinical trials are not disrupted, the number one challenge remains: adequate site selection.

Recent global events have created opportunities to reconfigure and transform how clinical trials operate. There are a number of ‘next normal’ business considerations to be addressed as the industry moves forward into a post-COVID era.

Julie Martin, CEO & co-Owner of Scimega Research looks to the future and how to identify key operational process and adaptations to help US sponsors optimally navigate the ‘new normal’ in clinical trial operations in Canada and other geographic areas. In this webinar, Julie will share strategies for how to leverage lessons learned in 2020 and put these into action to maximize clinical development progress in 2021-22.

Register for the live webinar on Wednesday, September 22, 2021 at 1pm EDT (12pm CDT/10am PDT) to learn more about:

  • Strategies used to mitigate threats in 2020 & 2021
  • How to continue successfully navigating the transition period
  • Cutting-edge small & mid-size oncology biotech trials: where to run them & decision factors for our choice of regions in 2021-2022

Bonus Offer: Register now and receive immediate access to the white paper Expert Guidance to Key Advantages of Canadian Regulatory Landscape.
For more information, or to register for this event, visit Optimally Navigating the ‘Next Normal’ for Oncology Clinical Trials.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Ayesha Rashid
Xtalks.com
+1 (416) 977-6555 x 272
Email >
Visit website